Menu
Not yet recruiting NCT06652217

Analysis of Occlusal Force Distribution in Digital and Conventional Occlusal Splint

No phase Interventional Bruxism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Digitally manufactured occlusal splint., conventionally manufactured occlusal splint.
Who it may be relevant to
Registry conditions: Bruxism. Basic parameters: 20 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Analysis of Occlusal Force Distribution in Digital and Conventional Occlusal Splint (Randomized Clinical Trial)

Overview

Each eligible patient will be randomly into one of two groups: Group A: The digital splint group, digital splint will be constructed to each patient. Group B: The conventional splint group, conventional splint will be constructed to each patient. * For both groups, thorough clinical examination, scaling and root-planning will be done. Patient will receive a motivational oral hygiene program with detailed explanation regarding the study process and outcome expectations. * A precise history and clinical examination will be done by (F.M) under supervision of Dr S.G. The digital splint construction method: * First, complete arch intraoral digital scans of the maxillary and mandibular arches will be performed using the intra oral scanner following the scanning protocol recommended by the manufacturer. * For inter maxillary relation recording using optical jaw tracking device, step-by-step procedure for tracking and recording the maxillomandibular relationship and mandibular motion by using an optical jaw tracking system will be illustrated to the patient. * The occlusal device will be designed using a CAD software program. * The occlusal device will be printed using a 3D printer * The occlusal device will be finished and polished manually. The conventional splint construction method: * The first step is making an impression using a quick-setting addition polyvinyl siloxane impression material. A stone model will be obtained after pouring the impression using extra-hard dental stone. * In the second visit a face bow transfer and a centric relation record will be utilized to mount the casts on a semi adjustable articulator. * For centric relation recording, a jig will be made with an incisal plateau from modeling plastic impression compound and the jig will be inserted between the central incisors. To measure centric relation as precisely as possible (by avoiding translational movement in the temporomandibular joint), * The jig will be adjusted with a scalpel to create a distance of no more than 2 mm between the maxillary and mandibular arches. Then the relation will be recorded using a fast-setting polyvinyl siloxane occlusal registration material. The occlusal registrations will be trimmed to the buccal cusp tips to be transferred accurately to the articulator without interference. * After mounting of the centric relation the protrusive record will be taken and the horizontal condylar angle will be adjusted accordingly. * The device will be fabricated from clear prosthetic resin. Production followed a standardized protocol with a minimum inter maxillary thickness of 1.5 mm and a buccal extension to 1 mm below the survey line. * The device will be finished and occlusion will be adjusted on the articulator. outcomes assessment: 1. Occlusal force distribution will be measured using osslusosense. 2. Cost effectiveness will be assessed using the following equation(CE ratio = C/E).

Interventions

  • Device Digitally manufactured occlusal splint.
    digitally manfactured occlusal splint using intra oral scanner and jaw traccking device for data acqusition and 3d printing for manfacturing of the device
  • Device conventionally manufactured occlusal splint
    the occlusal device will be manufactured conventionally using impression and and anterior deprogramer with bite registeration material for data aquesition and usual construction method using clear acrylic.

Primary outcome measures

  • occlusal force distribution [Time frame: the outcome will be measured immediately after the device insertion]
Secondary outcome measures (1)
  • cost effectiveness [Time frame: the outcome will be measured immediately after the device insertion]

Eligibility criteria

Inclusion Criteria:• Age range from 20 to 60 years old.

  • Medically healthy patients.
  • Patients with signs (as teeth attrition, muscles hypertrophy, and increased muscles activity) and symptoms (as muscles pain, headache, patient reporting) of bruxism for the last 6 months with no condylar or disc attrition.
  • Fully dentate with presence of first molar in both arches
  • Patients with good oral hygiene.
  • Absence of any intra-oral pathological condition. Exclusion Criteria:• Patients with a history of psychosomatic disease.
  • Patients with addiction to alcohol, drugs, or analgesics.
  • Pregnant patients.
  • Patients with malignant disease.
  • Acute events such as trauma or inflammation.
  • Bisphosphonate therapy within the last 5 years.
  • Removable dental prostheses.
  • Known hypersensitivity to materials.
  • Extensive temporomandibular disorder that renders the stabilizing splints not to be the treatment of choice.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06652217 · 2497 · ethics comittee

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗